1. Home
  2. YDES vs TFIN Comparison

YDES vs TFIN Comparison

Compare YDES & TFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YDES
  • TFIN
  • Stock Information
  • Founded
  • YDES 2013
  • TFIN 1981
  • Country
  • YDES Taiwan
  • TFIN United States
  • Employees
  • YDES N/A
  • TFIN N/A
  • Industry
  • YDES
  • TFIN Major Banks
  • Sector
  • YDES
  • TFIN Finance
  • Exchange
  • YDES Nasdaq
  • TFIN Nasdaq
  • Market Cap
  • YDES 1.1B
  • TFIN 1.2B
  • IPO Year
  • YDES N/A
  • TFIN N/A
  • Fundamental
  • Price
  • YDES $12.51
  • TFIN $55.13
  • Analyst Decision
  • YDES
  • TFIN Buy
  • Analyst Count
  • YDES 0
  • TFIN 4
  • Target Price
  • YDES N/A
  • TFIN $62.00
  • AVG Volume (30 Days)
  • YDES 46.8K
  • TFIN 298.0K
  • Earning Date
  • YDES 09-30-2025
  • TFIN 10-15-2025
  • Dividend Yield
  • YDES N/A
  • TFIN N/A
  • EPS Growth
  • YDES N/A
  • TFIN N/A
  • EPS
  • YDES N/A
  • TFIN 0.28
  • Revenue
  • YDES $510,360.00
  • TFIN $412,291,000.00
  • Revenue This Year
  • YDES N/A
  • TFIN $10.80
  • Revenue Next Year
  • YDES N/A
  • TFIN $11.33
  • P/E Ratio
  • YDES N/A
  • TFIN $198.90
  • Revenue Growth
  • YDES 45.76
  • TFIN 3.78
  • 52 Week Low
  • YDES $5.30
  • TFIN $42.90
  • 52 Week High
  • YDES $25.00
  • TFIN $110.58
  • Technical
  • Relative Strength Index (RSI)
  • YDES N/A
  • TFIN 50.59
  • Support Level
  • YDES N/A
  • TFIN $57.24
  • Resistance Level
  • YDES N/A
  • TFIN $61.26
  • Average True Range (ATR)
  • YDES 0.00
  • TFIN 2.84
  • MACD
  • YDES 0.00
  • TFIN 0.55
  • Stochastic Oscillator
  • YDES 0.00
  • TFIN 58.66

About YDES YD Bio Limited Ordinary Shares

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

About TFIN Triumph Financial Inc.

Triumph Financial Inc is a financial holding company. The company has four reportable segments namely Banking, Factoring, Payments, and Intelligence. The Banking segment includes the operations of TBK Bank. The Factoring segment includes the operations of Triumph Financial Services with revenue derived from factoring services, The Payments segment includes the operations of TBK Bank's TriumphPay division which provides a presentment, audit and payment solution to Shipper, Broker, and Factor clients in the trucking industry and The Intelligence segment includes to turn the over-the-road trucking data collected through the services into actionable insights for their customers.

Share on Social Networks: